ClinicalTrials.gov record
Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
ClinicalTrials.gov ID: NCT00518115
Public ClinicalTrials.gov record NCT00518115. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 16-Week, Parallel-Group, Double-Blind, Randomized, Placebo-Controlled, Multicenter, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of Multiple Doses and Multiple Treatment Regimens of GSK716155, With Byetta as an Open Label Active Reference, in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a placebo-controlled study in patients with Type 2 Diabetes Mellitus who are either taking no diabetes medication or who are taking metformin only. This study will investigate the safety, tolerability, and efficacy of Albiglutide (GSK716155) and will measure the levels of Albiglutide (GSK716155) in the bloodstream when it is given for 16 weeks. As a comparison, some subjects will receive exenatide instead of Albiglutide (GSK716155). The study will involve weekly visits for 17 weeks,and less frequent follow-up visits for an additional 10 weeks. Assessments include repeat blood sampling and monitoring of any side effects.
Study identification
- NCT ID
- NCT00518115
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 361 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2007 (Type not available)
- Primary completion
- May 2008 (Actual)
- Completion
- May 2008 (Actual)
- Last update posted
- Dec 16, 2016
2007 – 2008
United States locations
- U.S. sites
- 158
- U.S. states
- 37
- U.S. cities
- 145
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Anniston | Alabama | 36207 | — |
| GSK Investigational Site | Birmingham | Alabama | 35233 | — |
| GSK Investigational Site | Mobile | Alabama | 36617 | — |
| GSK Investigational Site | Bull Shoals | Arizona | 72619 | — |
| GSK Investigational Site | Glendale | Arizona | 85306 | — |
| GSK Investigational Site | Jonesboro | Arizona | 72401 | — |
| GSK Investigational Site | Phoenix | Arizona | 85032 | — |
| GSK Investigational Site | Harrisburg | Arkansas | 72432 | — |
| GSK Investigational Site | Jonesboro | Arkansas | 72401 | — |
| GSK Investigational Site | Little Rock | Arkansas | 72205 | — |
| GSK Investigational Site | Little Rock | Arkansas | 72211-3733 | — |
| GSK Investigational Site | Searcy | Arkansas | 72143 | — |
| GSK Investigational Site | Castro Valley | California | 94546 | — |
| GSK Investigational Site | Culver City | California | 90232 | — |
| GSK Investigational Site | Fullerton | California | 92835 | — |
| GSK Investigational Site | Garden Grove | California | 92843 | — |
| GSK Investigational Site | Huntington Beach | California | 92646 | — |
| GSK Investigational Site | Huntington Beach | California | 92648 | — |
| GSK Investigational Site | Huntington Park | California | 90255 | — |
| GSK Investigational Site | Lake Forest | California | 92630 | — |
| GSK Investigational Site | Loma Linda | California | 92354 | — |
| GSK Investigational Site | Los Angeles | California | 90022 | — |
| GSK Investigational Site | Orange | California | 92868 | — |
| GSK Investigational Site | Redwood City | California | 94062 | — |
| GSK Investigational Site | Reedley | California | 93654 | — |
| GSK Investigational Site | Riverside | California | 92506 | — |
| GSK Investigational Site | Sacramento | California | 95823 | — |
| GSK Investigational Site | Torrance | California | 90503 | — |
| GSK Investigational Site | Van Buys | California | 91405 | — |
| GSK Investigational Site | Ventura | California | 93003 | — |
| GSK Investigational Site | Victorville | California | 92395 | — |
| GSK Investigational Site | Denver | Colorado | 80220 | — |
| GSK Investigational Site | Trumbull | Connecticut | 06611 | — |
| GSK Investigational Site | Bradenton | Florida | 34205 | — |
| GSK Investigational Site | Clearwater | Florida | 33756 | — |
| GSK Investigational Site | Fort Lauderdale | Florida | 33316 | — |
| GSK Investigational Site | Gainesville | Florida | 32601 | — |
| GSK Investigational Site | Jacksonville | Florida | 32204 | — |
| GSK Investigational Site | Marianna | Florida | 32446 | — |
| GSK Investigational Site | Miami | Florida | 33144 | — |
| GSK Investigational Site | Oviedo | Florida | 32765 | — |
| GSK Investigational Site | Palm Harbor | Florida | 34684 | — |
| GSK Investigational Site | Plantation | Florida | 33317 | — |
| GSK Investigational Site | Tallahassee | Florida | 32308 | — |
| GSK Investigational Site | Tampa | Florida | 33603 | — |
| GSK Investigational Site | Winter Haven | Florida | 33881 | — |
| GSK Investigational Site | Winter Park | Florida | 32789 | — |
| GSK Investigational Site | Athens | Georgia | 30606 | — |
| GSK Investigational Site | Atlanta | Georgia | 30308 | — |
| GSK Investigational Site | Atlanta | Georgia | 30312 | — |
| GSK Investigational Site | Atlanta | Georgia | 30338 | — |
| GSK Investigational Site | Augusta | Georgia | 30909 | — |
| GSK Investigational Site | Columbus | Georgia | 31904 | — |
| GSK Investigational Site | Decatur | Georgia | 30032 | — |
| GSK Investigational Site | Perry | Georgia | 31069 | — |
| GSK Investigational Site | Suwanee | Georgia | 30024 | — |
| GSK Investigational Site | Tucker | Georgia | 30084 | — |
| GSK Investigational Site | Honolulu | Hawaii | 96813 | — |
| GSK Investigational Site | Meridian | Idaho | 83642 | — |
| GSK Investigational Site | Aurora | Illinois | 60504 | — |
| GSK Investigational Site | Evergreen Park | Illinois | 60805 | — |
| GSK Investigational Site | La Grange | Illinois | 60525 | — |
| GSK Investigational Site | Libertyville | Illinois | 60048 | — |
| GSK Investigational Site | Oak Brook | Illinois | 60523 | — |
| GSK Investigational Site | Watseka | Illinois | 60970 | — |
| GSK Investigational Site | Anderson | Indiana | 46011 | — |
| GSK Investigational Site | Indianapolis | Indiana | 46256 | — |
| GSK Investigational Site | South Bend | Indiana | 46601 | — |
| GSK Investigational Site | South Bend | Indiana | 46628 | — |
| GSK Investigational Site | Ames | Iowa | 50010 | — |
| GSK Investigational Site | Dubuque | Iowa | 52002 | — |
| GSK Investigational Site | Kansas City | Kansas | 66160 | — |
| GSK Investigational Site | Topeka | Kansas | 66606 | — |
| GSK Investigational Site | Lexington | Kentucky | 40504 | — |
| GSK Investigational Site | Covington | Louisiana | 70433 | — |
| GSK Investigational Site | Lacombe | Louisiana | 70433 | — |
| GSK Investigational Site | Metairie | Louisiana | 70006 | — |
| GSK Investigational Site | Haverhill | Massachusetts | 01831-2451 | — |
| GSK Investigational Site | Caro | Michigan | 48723 | — |
| GSK Investigational Site | Dearborn | Michigan | 48126 | — |
| GSK Investigational Site | Kalamazoo | Michigan | 49048 | — |
| GSK Investigational Site | Picayune | Mississippi | 39446 | — |
| GSK Investigational Site | Rolling Fork | Mississippi | 39159 | — |
| GSK Investigational Site | City of Saint Peters | Missouri | 63376 | — |
| GSK Investigational Site | Jefferson City | Missouri | 65109 | — |
| GSK Investigational Site | Springfield | Missouri | 65807 | — |
| GSK Investigational Site | Billings | Montana | 59101 | — |
| GSK Investigational Site | Lincoln | Nebraska | 68516 | — |
| GSK Investigational Site | North Platte | Nebraska | 69101 | — |
| GSK Investigational Site | Omaha | Nebraska | 68152 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89106 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89128 | — |
| GSK Investigational Site | Buffalo | New York | 14209 | — |
| GSK Investigational Site | Glens Falls | New York | 12801 | — |
| GSK Investigational Site | Rochester | New York | 14609 | — |
| GSK Investigational Site | Syracuse | New York | 13210 | — |
| GSK Investigational Site | Williamsville | New York | 14221 | — |
| GSK Investigational Site | Asheville | North Carolina | 28801 | — |
| GSK Investigational Site | Chadbourn | North Carolina | 28431 | — |
| GSK Investigational Site | Charlotte | North Carolina | 28204 | — |
| GSK Investigational Site | Charlotte | North Carolina | 28227 | — |
| GSK Investigational Site | Greensboro | North Carolina | 27455 | — |
| GSK Investigational Site | Mint Hill | North Carolina | 28227 | — |
| GSK Investigational Site | Raleigh | North Carolina | 27609 | — |
| GSK Investigational Site | Wilmington | North Carolina | 28401 | — |
| GSK Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| GSK Investigational Site | Bismarck | North Dakota | 58503 | — |
| GSK Investigational Site | Bismarck | North Dakota | 58504 | — |
| GSK Investigational Site | Fargo | North Dakota | 58104 | — |
| GSK Investigational Site | Fargo | North Dakota | 58122 | — |
| GSK Investigational Site | Grand Forks | North Dakota | 58201 | — |
| GSK Investigational Site | Cleveland | Ohio | 44122 | — |
| GSK Investigational Site | Columbus | Ohio | 43235 | — |
| GSK Investigational Site | Toledo | Ohio | 43606 | — |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73104 | — |
| GSK Investigational Site | Bend | Oregon | 97701 | — |
| GSK Investigational Site | Bensalem | Pennsylvania | 19020 | — |
| GSK Investigational Site | Harrisburg | Pennsylvania | 17112 | — |
| GSK Investigational Site | Morrisville | Pennsylvania | 19067 | — |
| GSK Investigational Site | Uniontown | Pennsylvania | 15401 | — |
| GSK Investigational Site | Watertown | South Dakota | 57201 | — |
| GSK Investigational Site | Bristol | Tennessee | 37620 | — |
| GSK Investigational Site | Clarksville | Tennessee | 37043 | — |
| GSK Investigational Site | Johnson City | Tennessee | 37604 | — |
| GSK Investigational Site | Knoxville | Tennessee | 37923 | — |
| GSK Investigational Site | Memphis | Tennessee | 38119 | — |
| GSK Investigational Site | Milan | Tennessee | 38358 | — |
| GSK Investigational Site | Nashville | Tennessee | 37203 | — |
| GSK Investigational Site | Cleburne | Texas | 76033 | — |
| GSK Investigational Site | Dallas | Texas | 75230 | — |
| GSK Investigational Site | Euless | Texas | 76040 | — |
| GSK Investigational Site | Houston | Texas | 77006 | — |
| GSK Investigational Site | Houston | Texas | 77030 | — |
| GSK Investigational Site | Houston | Texas | 77056 | — |
| GSK Investigational Site | Houston | Texas | 77070 | — |
| GSK Investigational Site | Houston | Texas | 77082 | — |
| GSK Investigational Site | LaPorte | Texas | 77571 | — |
| GSK Investigational Site | Lewisville | Texas | 75067 | — |
| GSK Investigational Site | Longview | Texas | 75605 | — |
| GSK Investigational Site | Midland | Texas | 79707 | — |
| GSK Investigational Site | Missouri City | Texas | 77459 | — |
| GSK Investigational Site | Pasadena | Texas | 77504 | — |
| GSK Investigational Site | Pearland | Texas | 77584 | — |
| GSK Investigational Site | Pharr | Texas | 78577 | — |
| GSK Investigational Site | Round Rock | Texas | 78664 | — |
| GSK Investigational Site | San Antonio | Texas | 78205 | — |
| GSK Investigational Site | San Marcos | Texas | 78666 | — |
| GSK Investigational Site | Spring | Texas | 77379 | — |
| GSK Investigational Site | Sugar Land | Texas | 77478 | — |
| GSK Investigational Site | The Woodlands | Texas | 77381 | — |
| GSK Investigational Site | Tomball | Texas | 77375 | — |
| GSK Investigational Site | Salt Lake City | Utah | 84107 | — |
| GSK Investigational Site | South Burlington | Vermont | 05403 | — |
| GSK Investigational Site | Chester | Virginia | 23836 | — |
| GSK Investigational Site | Manassas | Virginia | 20110 | — |
| GSK Investigational Site | Salem | Virginia | 24153 | — |
| GSK Investigational Site | Madison | Washington | 53717 | — |
| GSK Investigational Site | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00518115, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2016 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00518115 live on ClinicalTrials.gov.